{"name":"APACOR LIMITED","company_number":"03307222","status":"Active","type":"Private Limited Company","incorporated":"1997-01-24","dissolved":null,"registered_office":"Unit 5 The Sapphire Centre, Fishponds Road, Wokingham, Berkshire, RG41 2QL","postcode":"RG41 2QL","sic_codes":[{"code":32990,"description":"Other manufacturing not elsewhere classified"}],"principal_activity":"The principal activity of the company and group continued to be that of providers of medical diagnostic solutions.","previous_names":[{"name":"DIASYS LIMITED","changed_on":"2013-04-02"},{"name":"GENESISION LIMITED","changed_on":"2008-04-25"},{"name":"BRAND GENESIS LIMITED","changed_on":"1999-06-17"}],"warnings":[],"accounts":{"category":"Group","year_end":"31 December","last_made_up_to":"2025-12-31","next_due":"2027-09-30"},"employees":{"count":67,"accounts_date":"2025-12-31"},"financials":[{"financial_date":"2025-12-31","profit_loss":327608,"net_assets":9200617,"cash":1551174,"average_employees":67},{"financial_date":"2024-12-31","profit_loss":-270356,"net_assets":6813009,"cash":225523,"average_employees":67},{"financial_date":"2023-12-31","net_assets":7083365,"cash":342516},{"financial_date":"2022-12-31","net_assets":6658491,"cash":851500},{"financial_date":"2021-12-31","net_assets":4952241,"cash":722775}],"officers":{"current":2,"resigned":12,"complete":true,"note":"Names and details of individual officers are on the People page (subscriber-only on this site) and free at Companies House."},"charges":{"total":1,"outstanding":1},"gazette_notices":[],"insolvency_outcome":null,"ai_summary":"Apacor Limited presents a mixed risk profile: a well-established medical diagnostics manufacturer with strong net assets of £6.8M and confirmed going concern status, but facing acute working capital pressures evidenced by net current liabilities of £2.9M and a thin cash position of £226K. The 2024 operating loss and qualified audit opinion on stock valuation methodology add to concerns, though these appear partially driven by strategic expansion investments. The critical question for investors is whether the working capital deficit represents temporary timing around expansion or a structural liquidity constraint requiring external financing.","website":"https://apacor.com/","links":{"page":"https://www.companiesintheuk.co.uk/ltd/apacor-1","people":"https://www.companiesintheuk.co.uk/company/apacor-1/people","filing_history":"https://www.companiesintheuk.co.uk/company/apacor-1/filing-history","companies_house":"https://find-and-update.company-information.service.gov.uk/company/03307222","financials":"https://www.companiesintheuk.co.uk/company/apacor-1/financial","control":"https://www.companiesintheuk.co.uk/company/apacor-1/control","charges":"https://www.companiesintheuk.co.uk/company/apacor-1/charges","ai_analysis":"https://www.companiesintheuk.co.uk/company/apacor-1/analysis"},"source":"CompaniesInTheUK, from Companies House, The Gazette and other public registers (see /support/about). Cite as: CompaniesInTheUK, https://www.companiesintheuk.co.uk/ltd/apacor-1"}